Tan, I., Stinchcombe, T., Ready, N. E., Datto, M. B., Nagy, R. J., Gu, L., & Clarke, J. M. (2018). Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: A single institution, retrospective cohort study. In Journal of Clinical Oncology (Vol. 36, pp. e21222–e21222). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.e21222

Tan, Irena, Tom Stinchcombe, Neal E. Ready, Michael B. Datto, Rebecca J. Nagy, Lin Gu, and Jeffrey Melson Clarke. “Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: A single institution, retrospective cohort study.” In Journal of Clinical Oncology, 36:e21222–e21222. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e21222.

Tan I, Stinchcombe T, Ready NE, Datto MB, Nagy RJ, Gu L, et al. Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: A single institution, retrospective cohort study. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e21222–e21222.

Tan, Irena, et al. “Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: A single institution, retrospective cohort study.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. e21222–e21222. Crossref, doi:10.1200/jco.2018.36.15_suppl.e21222.

Tan I, Stinchcombe T, Ready NE, Datto MB, Nagy RJ, Gu L, Clarke JM. Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: A single institution, retrospective cohort study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e21222–e21222.